Back
Galectin Therapeutics Vs. SELLAS Life Sciences Group Industry Stock Comparison
Sell
14
GALT
Galectin Therapeutics
Last Price:
$1.03
Seasonality Move:
33.46%
Sell
6
SLS
SELLAS Life Sciences Group
Last Price:
$0.90
Seasonality Move:
2.47%
Sell
14
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
-
The current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
GALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
6
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
-
The current SELLAS Life Sciences Group [SLS] share price is $0.90. The Score for SLS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
SLS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $1.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $0.90The current trend is relatively stagnant and SLS is experiencing slight buying pressure.
GALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 20.76 | Sell |
Chaikin Money Flow: | -1963460 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.81) | Sell |
Bollinger Bands (100): | (2.2 - 2.82) | Sell |
SLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 35.76 | Sell |
Chaikin Money Flow: | 30714 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.93 - 1.23) | Sell |
Bollinger Bands (100): | (1.09 - 1.31) | Sell |
GALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.94 | Sell |
20-day SMA: | 2.26 | Sell |
50-day SMA: | 2.51 | Sell |
200-day SMA: | 2.64 | Sell |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 2.15 | Sell |
50-day EMA: | 2.4 | Sell |
200-day EMA: | 2.46 | Sell |
SLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.89 | Buy |
20-day SMA: | 1.04 | Sell |
50-day SMA: | 1.15 | Sell |
200-day SMA: | 1.24 | Sell |
8-day EMA: | 0.92 | Sell |
20-day EMA: | 1.01 | Sell |
50-day EMA: | 1.11 | Sell |
200-day EMA: | 1.21 | Sell |
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.
Galectin Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SELLAS Life Sciences Group Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |